Trial NCT04939272

View at ClinicalTrials.gov 
Org. Study IDs: 22043
Secondary IDs: 22043 NCI-2021-03219 P30CA033572

Last trial update was posted on 2023-12-15

MeSH Interventions

Venetoclax

MeSH Conditions

Lymphoma Lymphoma, Mantle-Cell

Other Conditions

Recurrent Mantle Cell Lymphoma Refractory Mantle Cell Lymphoma

Stopping Reasons

FDA Clinical Hold

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID